265 related articles for article (PubMed ID: 30624779)
1. Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cells.
Sewanan LR; Campbell SG
J Physiol; 2020 Jul; 598(14):2909-2922. PubMed ID: 30624779
[TBL] [Abstract][Full Text] [Related]
2. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
Eschenhagen T; Mummery C; Knollmann BC
Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
[TBL] [Abstract][Full Text] [Related]
3. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
[TBL] [Abstract][Full Text] [Related]
4. Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.
Buikema JW; Wu SM
Curr Cardiol Rep; 2017 Apr; 19(4):30. PubMed ID: 28315121
[TBL] [Abstract][Full Text] [Related]
5. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
[TBL] [Abstract][Full Text] [Related]
6. Genomic Engineering of Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Cavanaugh C; Hesson J; Mathieu J
Methods Mol Biol; 2024; 2735():129-143. PubMed ID: 38038847
[TBL] [Abstract][Full Text] [Related]
7. Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.
Li J; Feng X; Wei X
Stem Cell Res Ther; 2022 Jun; 13(1):232. PubMed ID: 35659761
[TBL] [Abstract][Full Text] [Related]
8. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
Ross SB; Fraser ST; Semsarian C
Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
[TBL] [Abstract][Full Text] [Related]
10. Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols.
Jeziorowska D; Fontaine V; Jouve C; Villard E; Dussaud S; Akbar D; Letang V; Cervello P; Itier JM; Pruniaux MP; Hulot JS
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587156
[TBL] [Abstract][Full Text] [Related]
11. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
[TBL] [Abstract][Full Text] [Related]
12. Disease Modeling and Disease Gene Discovery in Cardiomyopathies: A Molecular Study of Induced Pluripotent Stem Cell Generated Cardiomyocytes.
Kumar S; Curran JE; Kumar K; DeLeon E; Leandro AC; Peralta J; Williams-Blangero S; Blangero J
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805011
[TBL] [Abstract][Full Text] [Related]
13. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
[TBL] [Abstract][Full Text] [Related]
14. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients.
Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A
Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807
[TBL] [Abstract][Full Text] [Related]
15. New insights provided by myofibril mechanics in inherited cardiomyopathies.
Lin YH; Yap J; Ramachandra CJA; Hausenloy DJ
Cond Med; 2019 Oct; 2(5):213-224. PubMed ID: 32133438
[TBL] [Abstract][Full Text] [Related]
16. Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.
Schick R; Mekies LN; Shemer Y; Eisen B; Hallas T; Ben Jehuda R; Ben-Ari M; Szantai A; Willi L; Shulman R; Gramlich M; Pane LS; My I; Freimark D; Murgia M; Santamaria G; Gherghiceanu M; Arad M; Moretti A; Binah O
PLoS One; 2018; 13(10):e0205719. PubMed ID: 30332462
[TBL] [Abstract][Full Text] [Related]
17. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
[TBL] [Abstract][Full Text] [Related]
18. Modeling of human cardiomyopathy with induced pluripotent stem cells.
Lee YK; Ng KM; Tse HF
J Biomed Nanotechnol; 2014 Oct; 10(10):2562-85. PubMed ID: 25992409
[TBL] [Abstract][Full Text] [Related]
19. ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy.
Phelan DG; Anderson DJ; Howden SE; Wong RC; Hickey PF; Pope K; Wilson GR; Pébay A; Davis AM; Petrou S; Elefanty AG; Stanley EG; James PA; Macciocca I; Bahlo M; Cheung MM; Amor DJ; Elliott DA; Lockhart PJ
Eur Heart J; 2016 Sep; 37(33):2586-90. PubMed ID: 27106955
[TBL] [Abstract][Full Text] [Related]
20. Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.
Khedro T; Duran JM; Adler ED
Curr Cardiol Rep; 2022 Jun; 24(6):631-644. PubMed ID: 35657495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
